187 related articles for article (PubMed ID: 29635947)
1. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M
Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):429-434. PubMed ID: 29635947
[TBL] [Abstract][Full Text] [Related]
2. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Komori H; Saito S; Kusuhara H; Tamai I; Ieiri I; Uno T; Yasui-Furukori N
Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
[TBL] [Abstract][Full Text] [Related]
3. [Determinants of the stereoselective pharmacokinetics of fexofenadine].
Akamine Y
Yakugaku Zasshi; 2015; 135(3):473-81. PubMed ID: 25759055
[TBL] [Abstract][Full Text] [Related]
4. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
Akamine Y; Miura M; Komori H; Tamai I; Ieiri I; Yasui-Furukori N; Uno T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
Akamine Y; Miura M; Yasui-Furukori N; Ieiri I; Uno T
J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
[TBL] [Abstract][Full Text] [Related]
6. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of fexofenadine enantiomers.
Miura M; Uno T
Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):69-74. PubMed ID: 19947891
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.
Togami K; Tosaki Y; Chono S; Morimoto K; Hayasaka M; Tada H
J Pharm Pharmacol; 2013 Jan; 65(1):22-9. PubMed ID: 23215684
[TBL] [Abstract][Full Text] [Related]
9. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
Tateishi T; Miura M; Suzuki T; Uno T
Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
[TBL] [Abstract][Full Text] [Related]
10. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
11. Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.
Medwid S; Li MMJ; Knauer MJ; Lin K; Mansell SE; Schmerk CL; Zhu C; Griffin KE; Yousif MD; Dresser GK; Schwarz UI; Kim RB; Tirona RG
Drug Metab Dispos; 2019 Aug; 47(8):832-842. PubMed ID: 31123035
[TBL] [Abstract][Full Text] [Related]
12. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
Pinto L; Bapat P; de Lima Moreira F; Lubetsky A; de Carvalho Cavalli R; Berger H; Lanchote VL; Koren G
Pharm Res; 2021 Apr; 38(4):647-655. PubMed ID: 33825113
[TBL] [Abstract][Full Text] [Related]
13. The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.
Imanaga J; Kotegawa T; Imai H; Tsutsumi K; Yoshizato T; Ohyama T; Shirasaka Y; Tamai I; Tateishi T; Ohashi K
Pharmacogenet Genomics; 2011 Feb; 21(2):84-93. PubMed ID: 21280267
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Yasui-Furukori N; Kojima M; Uno T
Br J Clin Pharmacol; 2012 Mar; 73(3):478-81. PubMed ID: 21950458
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
Miura M; Uno T; Tateishi T; Suzuki T
Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
[TBL] [Abstract][Full Text] [Related]
16. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study.
Pinto LSR; Vale GTD; Moreira FL; Marques MP; Coelho EB; Cavalli RC; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122094. PubMed ID: 32311673
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
Sakugawa T; Miura M; Hokama N; Suzuki T; Tateishi T; Uno T
Br J Clin Pharmacol; 2009 May; 67(5):535-40. PubMed ID: 19552748
[TBL] [Abstract][Full Text] [Related]
18. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Dresser GK; Kim RB; Bailey DG
Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
[TBL] [Abstract][Full Text] [Related]
19. Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects.
Kusuhara H; Miura M; Yasui-Furukori N; Yoshida K; Akamine Y; Yokochi M; Fukizawa S; Ikejiri K; Kanamitsu K; Uno T; Sugiyama Y
Drug Metab Dispos; 2013 Jan; 41(1):206-13. PubMed ID: 23115085
[TBL] [Abstract][Full Text] [Related]
20. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
Kamath AV; Yao M; Zhang Y; Chong S
J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]